MARKET

CTSO

CTSO

Cytosorbents Corp
NASDAQ
0.3600
-0.0094
-2.54%
After Hours: 0.3600 0 0.00% 16:46 07/17 EDT
OPEN
0.3550
PREV CLOSE
0.3694
HIGH
0.3753
LOW
0.3500
VOLUME
78.05K
TURNOVER
--
52 WEEK HIGH
1.220
52 WEEK LOW
0.3500
MARKET CAP
22.62M
P/E (TTM)
-1.8868
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CTSO last week (0706-0710)?
Weekly Report · 5d ago
Cytosorbents Faces Nasdaq Compliance and Delisting Risk
TipRanks · 07/06 20:37
CytoSorbents gets Nasdaq notice for falling below $35 million market value threshold
PUBT · 07/06 20:06
Weekly Report: what happened at CTSO last week (0629-0703)?
Weekly Report · 07/06 10:15
Weekly Report: what happened at CTSO last week (0622-0626)?
Weekly Report · 06/29 10:10
CytoSorbents Advances FDA Pathway for DrugSorb Programs
TipRanks · 06/25 13:48
CytoSorbents posts investor presentation outlining blood purification products, DrugSorb-ATR regulatory path
PUBT · 06/25 13:28
Weekly Report: what happened at CTSO last week (0615-0619)?
Weekly Report · 06/22 10:19
More
About CTSO
CytoSorbents Corporation is engaged in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. The Company’s blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its lead product, CytoSorb, is an extracorporeal blood purification cartridge to reduce cytokine storms in common critical illnesses that can lead to massive inflammation, organ failure and patient death. Its products also include ECOS-300CY, VetResQ, DrugSorb-ATR, and PuriFi. DrugSorb-ATR is an investigational device that uses equivalent polymer technology to CytoSorb to address a large unmet need for blood thinner reversal in cardiothoracic surgery. ECOS-300CY is used to reduce cytokines and other inflammatory mediators when used in an ex vivo organ perfusion system.

Webull offers Cytosorbents Corp stock information, including NASDAQ: CTSO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CTSO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CTSO stock methods without spending real money on the virtual paper trading platform.